Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Henan Tianfang Huazhong Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and finished dosage forms. As a key subsidiary of Henan Tianfang Pharmaceutical Co., Ltd., it operates under the umbrella of the state-owned China Meheco Group. The company is recognized as one of the world's largest production bases for spiramycin and acetylspiramycin, serving both domestic and international markets. Its product portfolio extends beyond antibiotics to include cardiovascular, anti-diabetic, and gastrointestinal medications. The firm maintains rigorous quality standards with multiple GMP-certified production lines for fermentation and chemical synthesis. Strategically located in Zhumadian, Henan, the company plays a vital role in the industrial chain of its parent group by providing high-quality raw materials and generic drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Henan Tianfang Huazhong Pharmaceutical.